This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Elbourne, K B Articles by McMurray, R W Search for Related Content PubMed PubMed Citation Articles by Elbourne, K B Articles by McMurray, R W Social Bookmarking                         What's this?

Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus

University of Mississippi Medical Center, Jackson, MS; University of Mississippi Medical Center, Jackson, MS, USA

D Keisler

University of Missouri, Columbia, MO; University of Mississippi Medical Center, Jackson, MS, USA

R W McMurray

G.V. (Sonny) Montgomery VAMC; University of Mississippi Medical Center, Jackson, MS, USA

Estrogen and prolactin have been shown to modulate autoimmunity in the NZB/NZW F1 (B/W) mouse model of systemic lupus erythematosus (SLE). However, estrogen stimulates prolactin secretion. The goal of this study was to examine differential effects of estrogen and prolactin in the female B/W mouse model of SLE. B/W females were manipulated to create combinations of low and high concentrations of serum estrogen and prolactin. Hyperprolactinemic mice with either low or high serum estrogen levels had accelerated development of albuminuria at 24 and 32 weeks of age compared to normal and hypoprolatinemic mice. High estrogen/high prolactin mice also had a higher percentage of anti-DNA antibodies compared to mice in the low estrogen/low prolactin and the high estrogen/low prolactin groups. IgG levels were not significantly different between groups. Mean survival was shortest in the high estrogen/high prolactin group (34 1.0 weeks) and longest in the high estrogen/low prolactin group (42 1.2 weeks; P < 0.05). High levels of serum estrogen were associated with depressed in vitro lymphoproliferation and IL-2 production. This study suggests that high prolactin levels in either high or low serum estrogen states are associated with accelerated autoimmunity in the B/W mouse. This study further demonstrates that high estrogen levels do not accelerate murine SLE when the prolactin-stimulating property of estrogen is suppressed by bromocriptine. Further investigation of hormonal interactions in autoimmunity will provide a better understanding of hormonal immunoregulation and, perhaps, lead to improved clinical application of hormonal immunomodulation.

Key Words: lupus • estrogen • prolactin • hormone • mice

Lupus, Vol. 7, No. 6, 420-427 (1998)
DOI: 10.1191/096120398678920352


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J Li and R. McMurray Effects of chronic exposure to DDT and TCDD on disease activity in murine systemic lupus erythematosus Lupus, October 1, 2009; 18(11): 941 - 949. [Abstract] [PDF]

				M Petri Sex hormones and systemic lupus erythematosus Lupus, May 1, 2008; 17(5): 412 - 415. [Abstract] [PDF]

				A. Bachelot and N. Binart Reproductive role of prolactin Reproduction, February 1, 2007; 133(2): 361 - 369. [Abstract] [Full Text] [PDF]

				L Daza, C Lavalle, C Duarte, R Huerta, and J Moreno Lack of association between hyperprolactinemia and soluble IL-2 receptor levels in systemic lupus erythematosus Lupus, February 1, 2003; 12(2): 107 - 111. [Abstract] [PDF]

				S E Walker and L.-y. Yu-Lee Overview: prolactin and autoimmunity Lupus, October 1, 2001; 10(10): 659 - 659. [PDF]

				L.-y. Yu-Lee Stimulation of interferon regulatory factor-1 by prolactin Lupus, October 1, 2001; 10(10): 691 - 699. [Abstract] [PDF]

				A M Walker Unmodified and phosphorylated prolactin and gamma delta T cell development and function Lupus, October 1, 2001; 10(10): 735 - 741. [Abstract] [PDF]

				R W McMurray Prolactin in murine systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 742 - 747. [Abstract] [PDF]

				S E Walker Bromocriptine treatment of systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 762 - 768. [Abstract] [PDF]

				A M Jacobi, W Rohde, M Ventz, G Riemekasten, G-R Burmester, and F Hiepe Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity Lupus, August 1, 2001; 10(8): 554 - 561. [Abstract] [PDF]

				S E Walker Treatment of systemic lupus erythematosus with bromocriptine Lupus, March 1, 2001; 10(3): 197 - 202. [Abstract] [PDF]

				A M Jacobi, W Rohde, H-D Volk, T Dorner, G-R Burmester, and F Hiepe Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls Ann Rheum Dis, March 1, 2001; 60(3): 242 - 247. [Abstract] [Full Text] [PDF]

				R. K. Agarwal, C.-C. Chan, B. Wiggert, and R. R. Caspi Pregnancy Ameliorates Induction and Expression of Experimental Autoimmune Uveitis J. Immunol., March 1, 1999; 162(5): 2648 - 2654. [Abstract] [Full Text] [PDF]

				S E Walker, D Miller, D L Hill, and G R Komatireddy Prolactin, a pituitary hormone that modifies immune responses: Proceedings of the Mini-symposium on Prolactin and SLE, held at the 5th International Conference on Systemic Lupus Erythematosus, Cancun, Mexico Lupus, July 1, 1998; 7(6): 371 - 375. [PDF]